Patent US4446140A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4446140A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and composition for treating mouth pain

Assignee: Whitby Research Inc
•
Filing: 1982-03-29
•
Granted: 1984-05-01
•
Expires: 2002-03-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for treating mouth pain by administering to a human having such pain an effective mouth pain reducing amount of dextromethorphan, preferably as the hydrobromide.

Inventors

  • 👤 Eric L. Nelson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 12:08
CPC Classifications
A; A61; A61K; A61K45/00; A61K45/06; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485; A61K31/60

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 34 words
A method of temporarily reducing pain and discomfort associated with mouth pain comprising administering to a human having mouth pain an effective mouth pain reducing amount of dextromethorphan or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim 34 words
A method of temporarily reducing pain and discomfort associated with mouth pain comprising administering to a human having mouth pain an effective mouth pain reducing amount of dextromethorphan or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 23 words
The method of claim 1 wherein the dextromethorphan is administered in a daily dosage regimen of about 5 mg to about 500 mg.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein the dextromethorphan is administered in a daily dosage regimen of about 10 mg to about 200 mg.
Claim 5
Dependent Claim 17 words
The method of claim 1 wherein the dextromethorphan is administered in the form of its hydrobromide salt.
Claim 6
Dependent Claim 12 words
The method of claim 4 wherein the dextromethorphan hydrobromide is administered orally.
Claim 7
Dependent Claim 29 words
The method of claim 1 wherein the dextromethorphan is administered in an oral dosage form selected from the group consisting of a tablet, capsule, lozenge, syrup, suspension and elixir.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-05-01 1987-10-31 1988-05-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-05-01 1991-10-31 1992-05-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-05-01 1995-10-31 1996-05-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag